Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections

The masseter is the most targeted muscle when treating hypertrophy to produce a smooth face shape. Compensatory hypertrophy is a well known clinical sequela that occurs in botulinum neurotoxin (BoNT) treatments and is limited to the lower part of the masseter. Based on the masseteric hypertrophy pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyu-Lim, Cho, Hyun Jin, Bae, Hyungkyu, Park, Hyun Jin, Park, Min Sun, Kim, Hee-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150825/
https://www.ncbi.nlm.nih.gov/pubmed/32235784
http://dx.doi.org/10.3390/toxins12030202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150825/
https://www.ncbi.nlm.nih.gov/pubmed/32235784
http://dx.doi.org/10.3390/toxins12030202

Ejemplares similares